Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
BMC Biochemistry
|
December 1, 2007
Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling
Dino Bullinger, Hans Neubauer, Tanja Fehm, et al.
Archives of Internal Medicine
|
May 9, 2002
Using trade names: a risk factor for accidental drug overdose
Matthias Schwab, Carsten Oetzel, Klaus Mörike, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung
|
January 14, 2005
[Rationale and methods of the UNAMET study (dose- and CYP2D6-genotype-dependent adverse drug reactions of metoprolol)--a contribution to quality improvement in pharmacotherapy]
Richard Fux, Christoph Meisner, Matthias Schwab, et al.
Analytical and Bioanalytical Chemistry
|
October 21, 2005
Stereospecific pharmacokinetic characterisation of phenprocoumon metabolites, and mass-spectrometric identification of two novel metabolites in human plasma and liver microsomes
Bernd Kammerer, Rainer Kahlich, Mike Ufer, et al.
The American Journal of Tropical Medicine and Hygiene
|
March 3, 2004
Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood)
Karin Räth, Katja Taxis, Gitta Walz, et al.
Analytical Biochemistry
|
November 3, 2004
Mass spectrometric pathway monitoring of secondary metabolites: systematic analysis of culture extracts of Streptomyces species
Bernd Kammerer, Rainer Kahlich, Stefan Laufer, et al.
Analytical and Bioanalytical Chemistry
|
May 21, 2005
Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS coupling
Bernd Kammerer, Antje Frickenschmidt, Christa E Müller, et al.
Journal of Clinical Pharmacology
|
May 21, 2010
No dose adjustment on coadministration of the PDE4 inhibitor roflumilast with a weak CYP3A, CYP1A2, and CYP2C19 inhibitor: an investigation using cimetidine
Gabriele M Böhmer, Christoph H Gleiter, Klaus Mörike, et al.
International Journal of Molecular Sciences
|
February 22, 2014
Interplay between endothelin and erythropoietin in astroglia: the role in protection against hypoxia
Richard Schäfer, Lars Mueller, Reinhild Buecheler, et al.
European Journal of Clinical Pharmacology
|
May 15, 2010
Pharmacokinetics of natural mistletoe lectins after subcutaneous injection
Roman Huber, Jürgen Eisenbraun, Barbara Miletzki, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
BMC Biochemistry
|
December 1, 2007
Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling
Dino Bullinger, Hans Neubauer, Tanja Fehm, et al.
Archives of Internal Medicine
|
May 9, 2002
Using trade names: a risk factor for accidental drug overdose
Matthias Schwab, Carsten Oetzel, Klaus Mörike, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung
|
January 14, 2005
[Rationale and methods of the UNAMET study (dose- and CYP2D6-genotype-dependent adverse drug reactions of metoprolol)--a contribution to quality improvement in pharmacotherapy]
Richard Fux, Christoph Meisner, Matthias Schwab, et al.
Analytical and Bioanalytical Chemistry
|
October 21, 2005
Stereospecific pharmacokinetic characterisation of phenprocoumon metabolites, and mass-spectrometric identification of two novel metabolites in human plasma and liver microsomes
Bernd Kammerer, Rainer Kahlich, Mike Ufer, et al.
The American Journal of Tropical Medicine and Hygiene
|
March 3, 2004
Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood)
Karin Räth, Katja Taxis, Gitta Walz, et al.
Analytical Biochemistry
|
November 3, 2004
Mass spectrometric pathway monitoring of secondary metabolites: systematic analysis of culture extracts of Streptomyces species
Bernd Kammerer, Rainer Kahlich, Stefan Laufer, et al.
Analytical and Bioanalytical Chemistry
|
May 21, 2005
Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS coupling
Bernd Kammerer, Antje Frickenschmidt, Christa E Müller, et al.
Journal of Clinical Pharmacology
|
May 21, 2010
No dose adjustment on coadministration of the PDE4 inhibitor roflumilast with a weak CYP3A, CYP1A2, and CYP2C19 inhibitor: an investigation using cimetidine
Gabriele M Böhmer, Christoph H Gleiter, Klaus Mörike, et al.
International Journal of Molecular Sciences
|
February 22, 2014
Interplay between endothelin and erythropoietin in astroglia: the role in protection against hypoxia
Richard Schäfer, Lars Mueller, Reinhild Buecheler, et al.
European Journal of Clinical Pharmacology
|
May 15, 2010
Pharmacokinetics of natural mistletoe lectins after subcutaneous injection
Roman Huber, Jürgen Eisenbraun, Barbara Miletzki, et al.
Page
of 7